Martine Alhenc-Gelas Selected Research

Martine Alhenc-Gelas Research Topics

Disease

11	Venous Thromboembolism 09/2020 - 08/2002
11	Venous Thrombosis (Deep-Vein Thrombosis) 09/2020 - 04/2003
7	Thrombocytopenia (Thrombopenia) 10/2021 - 09/2006
6	Thrombosis (Thrombus) 12/2016 - 08/2003
4	Activated Protein C Resistance (APC Resistance) 02/2017 - 09/2003
4	Protein S Deficiency (Deficiency, Protein S) 01/2017 - 04/2003
3	Hemorrhage 12/2016 - 04/2002
2	Wounds and Injuries (Trauma) 01/2021 - 07/2012
2	Protein C Deficiency 01/2018 - 01/2004
2	Inflammation (Inflammations) 01/2018 - 04/2016
2	Coronary Disease (Coronary Heart Disease) 06/2011 - 05/2006
2	Fever (Fevers) 01/2005 - 08/2003
1	Congenital Disorders of Glycosylation 01/2018
1	Multiple Abnormalities 01/2018
1	Hypoprothrombinemias (Prothrombin Deficiency) 04/2015
1	Arthritis (Polyarthritis) 04/2015
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2014
1	Thromboembolism 03/2013
1	Pulmonary Embolism 07/2012
1	Ischemic Stroke 06/2011
1	Hypertension (High Blood Pressure) 05/2006
1	Necrosis 01/2004
1	Protein Deficiency 08/2003
1	Factor VII Deficiency (Hypoproconvertinemia) 04/2002
1	Disease Susceptibility (Diathesis) 04/2002
1	Carotid Artery Diseases 02/2002
1	Atherosclerosis 02/2002

Drug/Important Bio-Agent (IBA)

9	AntithrombinsIBA 01/2018 - 08/2003
7	Heparin (Liquaemin)FDA LinkGeneric 10/2021 - 09/2006
5	Protein CIBA 09/2020 - 09/2003
5	factor V LeidenIBA 01/2014 - 08/2002
4	Estrogens (Estrogen)FDA Link 11/2010 - 09/2003
3	Hormones (Hormone)IBA 08/2011 - 11/2005
2	Oral ContraceptivesIBA 09/2020 - 03/2011
2	AnticoagulantsIBA 09/2020 - 01/2018
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018 - 11/2006
2	RivaroxabanIBA 01/2018 - 07/2014
2	Prothrombin (Factor II)IBA 02/2017 - 08/2002
2	Thrombin FDA Link 08/2011 - 06/2011
2	Progestins (Progestagens)IBA 03/2011 - 11/2010
2	lepirudin (Refludan)FDA Link 03/2011 - 09/2006
2	SerpinsIBA 06/2006 - 08/2003
2	AntigensIBA 05/2006 - 01/2005
1	AntibodiesIBA 10/2021
1	Serotonin (5 Hydroxytryptamine)IBA 10/2021
1	RNA Splice SitesIBA 09/2020
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Polysaccharides (Glycans)IBA 01/2018
1	CarbohydratesIBA 01/2018
1	Protein SIBA 02/2017
1	Contraceptive Agents (Contraceptives)IBA 02/2017
1	danaparoid (Orgaran)FDA Link 12/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2016
1	Rosuvastatin Calcium (Crestor)FDA Link 04/2016
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 04/2015
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2012
1	FibrinIBA 08/2011
1	Biomarkers (Surrogate Marker)IBA 08/2011
1	Biological ProductsIBA 03/2011
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 03/2011
1	PlasminogenIBA 03/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2011
1	fibrin fragment D (D-dimer)IBA 03/2011
1	Progesterone FDA LinkGeneric 11/2010
1	NorpregnanesIBA 11/2010
1	antithrombin Cambridge IIIBA 10/2007
1	Fibrinogen (Factor I)FDA Link 05/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2006
1	Triglycerides (Triacylglycerol)IBA 05/2006
1	CholesterolIBA 05/2006
1	Plasminogen InactivatorsIBA 05/2006
1	Glucose (Dextrose)FDA LinkGeneric 05/2006
1	Plasminogen Activator Inhibitor 1IBA 05/2006
1	Nadroparin (Nadroparin Calcium)IBA 01/2004
1	coumarinIBA 01/2004
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 08/2002
1	Factor VII (Proconvertin)IBA 04/2002
1	ThrombomodulinIBA 02/2002

Therapy/Procedure

6	Therapeutics 12/2016 - 01/2004
2	Estrogen Replacement Therapy 09/2003 - 02/2002
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2021
1	Art Therapy 04/2016
1	Contraception (Birth Control) 11/2006
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 02/2002